Megabecquerel to Millicurie

Diagnostic imaging doses fall neatly in the MBq range — a PET scan uses 185–370 MBq, a bone scan 500–800 MBq. Using becquerels would mean writing hundreds of millions; using gigabecquerels would mean awkward decimals like 0.37 GBq. MBq is the Goldilocks unit for the hospital pharmacy: large enough to avoid scientific notation, small enough to express a single patient dose as a tidy number on a syringe label.

That depends entirely on the isotope. Technetium-99m, the workhorse of diagnostic imaging, has a 6-hour half-life — so a 740 MBq injection drops to 370 MBq in 6 hours, 185 MBq in 12, and becomes negligible within 2 days. Fluorine-18 (used in PET) has a 110-minute half-life and is essentially gone in a day. Iodine-131 (used in therapy) lingers for about 8 days per half-life. Hospitals choose isotopes partly based on how fast they want the activity to vanish.

Most diagnostic isotopes (Tc-99m, F-18) have half-lives under a day, so hospitals simply store waste in shielded bins and let it decay. After 10 half-lives — about 3 days for Tc-99m — the activity is down to less than 0.1% of the original and can be disposed of as normal clinical waste. Longer-lived therapeutic isotopes like I-131 require weeks of decay storage. The vast majority of nuclear medicine waste is never shipped to a radioactive disposal site; it just sits in a locked closet until physics solves the problem.

A patient injected with 370 MBq of F-18 for a PET scan emits gamma rays at a dose rate of roughly 5–6 µSv/hr at one meter. That means sitting next to them for two hours gives you about 10–12 µSv — less than a chest X-ray. Staff handle dozens of patients daily so they follow time-and-distance protocols, but for family members the exposure from a single visit is trivially small. The activity halves every 110 minutes, so by evening the patient is barely distinguishable from background.

Molybdenum-99, which decays into the technetium-99m used in 30+ million scans per year worldwide, can only be produced in a handful of aging research reactors. It has a 66-hour half-life so it cannot be stockpiled — you have to make it, ship it, and use it within days. When a reactor goes down for maintenance (as happened in 2009 when both the Canadian NRU and Dutch HFR shut down simultaneously), hospitals worldwide face scan cancellations within a week. New production methods using particle accelerators and LEU targets are slowly diversifying supply.

Yes, and it creates real problems. If a patient who received therapeutic I-131 (30–200 mCi) dies within days, the body can trigger radiation alarms at funeral homes and crematoria. Cremation is the bigger concern — burning the body aerosolises the isotope, contaminating the crematorium and potentially exposing workers. Most radiation safety programs require a waiting period before cremation, or direct burial with notification to the funeral director. In 2019, an Arizona crematorium unknowingly cremated a patient with residual lutetium-177, contaminating the facility. Hospitals are supposed to flag these cases, but the system is imperfect.

The radiopharmacist draws the Tc-99m solution into a syringe, places it in a dose calibrator (a pressurized argon ionisation chamber), and reads the activity in mCi or MBq. Because the isotope is decaying constantly — Tc-99m loses half its activity every 6 hours — the calibrator reading must be decay-corrected to the planned injection time. If the scan is at 2pm and the dose is drawn at 10am, the pharmacist dispenses more than the prescribed 20 mCi, knowing it will decay to exactly 20 mCi by injection. Timing is everything.

The Tc-99m bone scan, with about 20–25 mCi (740–925 MBq) injected intravenously. Technetium-99m accumulates in areas of high bone turnover — fractures, infections, metastases — and emits 140 keV gamma rays that a gamma camera images. The scan itself takes 2–3 hours (allowing time for the tracer to distribute), and the patient's radioactivity drops to negligible levels within 24–48 hours. Over 30 million Tc-99m procedures are performed worldwide each year, making it by far the most-used medical radioisotope.

Technically yes, but radiation detectors at airports, borders, and government buildings may alarm for days after certain scans. A patient who received 10 mCi of I-131 can trigger a portal monitor for up to 3 months. Most nuclear medicine departments provide a wallet card explaining the procedure, isotope, and date — TSA and customs agents are trained to recognize these. The actual radiation risk to fellow passengers is negligible; the issue is entirely about security system sensitivity, not safety.

Hyperthyroidism treatment aims to kill just enough thyroid tissue to normalize hormone production — typically 5–15 mCi (185–555 MBq) of I-131. Thyroid cancer ablation aims to destroy every remaining thyroid cell after surgery and kill any metastases — that takes 30–200 mCi (1.1–7.4 GBq). The higher doses require inpatient isolation and more aggressive radiation safety precautions. Some oncologists are exploring whether lower ablation doses (30 mCi) work as well as high ones (100+ mCi) for low-risk cancers — the evidence is surprisingly close.